相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Arming T cells to halt malaria
Michael F. Good et al.
NATURE MEDICINE (2011)
Blood-stage malaria vaccines - recent progress and future challenges
A. L. Goodman et al.
ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY (2010)
Regulation of immunity to Plasmodium: Implications from mouse models for blood stage malaria vaccine design
Andrew W. Taylor-Robinson
EXPERIMENTAL PARASITOLOGY (2010)
Growth-Inhibitory Antibodies Are Not Necessary for Protective Immunity to Malaria Infection
E. Elsa Herdiana Murhandarwati et al.
INFECTION AND IMMUNITY (2010)
In Vitro Growth-Inhibitory Activity and Malaria Risk in a Cohort Study in Mali
Peter D. Crompton et al.
INFECTION AND IMMUNITY (2010)
Prime-Boost Immunization with Adenoviral and Modified Vaccinia Virus Ankara Vectors Enhances the Durability and Polyfunctionality of Protective Malaria CD8(+) T-Cell Responses
Arturo Reyes-Sandoval et al.
INFECTION AND IMMUNITY (2010)
New Candidate Vaccines against Blood-Stage Plasmodium falciparum Malaria: Prime-Boost Immunization Regimens Incorporating Human and Simian Adenoviral Vectors and Poxviral Vectors Expressing an Optimized Antigen Based on Merozoite Surface Protein 1
Anna L. Goodman et al.
INFECTION AND IMMUNITY (2010)
Low doses of killed parasite in CpG elicit vigorous CD4+ T cell responses against blood-stage malaria in mice
Alberto Pinzon-Charry et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Enhancing Blood-Stage Malaria Subunit Vaccine Immunogenicity in Rhesus Macaques by Combining Adenovirus, Poxvirus, and Protein-in-Adjuvant Vaccines
Simon J. Draper et al.
JOURNAL OF IMMUNOLOGY (2010)
A Phase 1/2 Study of a Multiclade HIV-1 DNA Plasmid Prime and Recombinant Adenovirus Serotype 5 Boost Vaccine in HIV-Uninfected East Africans (RV 172)
Hannah Kibuuka et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Viruses as vaccine vectors for infectious diseases and cancer
Simon J. Draper et al.
NATURE REVIEWS MICROBIOLOGY (2010)
Clinical Protection from Falciparum Malaria Correlates with Neutrophil Respiratory Bursts Induced by Merozoites Opsonized with Human Serum Antibodies
Charlotte Joos et al.
PLOS ONE (2010)
Adenovectors induce functional antibodies capable of potent inhibition of blood stage malaria parasite growth
Joseph T. Bruder et al.
VACCINE (2010)
The IC50 of anti-Pfs25 antibody in membrane-feeding assay varies among species
Lediya Cheru et al.
VACCINE (2010)
Tailoring subunit vaccine immunogenicity: Maximizing antibody and T cell responses by using combinations of adenovirus, poxvirus and protein-adjuvant vaccines against Plasmodium falciparum MSP1
Alexander D. Douglas et al.
VACCINE (2010)
Recombinant Viral Vaccines Expressing Merozoite Surface Protein-1 Induce Antibody- and T Cell-Mediated Multistage Protection against Malaria
Simon J. Draper et al.
CELL HOST & MICROBE (2009)
Anti-Apical-Membrane-Antigen-1 Antibody Is More Effective than Anti-42-Kilodalton-Merozoite-Surface-Protein-1 Antibody in Inhibiting Plasmodium falciparum Growth, as Determined by the In Vitro Growth Inhibition Assay
Kazutoyo Miura et al.
CLINICAL AND VACCINE IMMUNOLOGY (2009)
Protection against a Malaria Challenge by Sporozoite Inoculation.
Meta Roestenberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Do we still need a malaria vaccine?
B. Greenwood et al.
PARASITE IMMUNOLOGY (2009)
Phase 1/2a Study of the Malaria Vaccine Candidate Apical Membrane Antigen-1 (AMA-1) Administered in Adjuvant System AS01B or AS02A
Michele D. Spring et al.
PLOS ONE (2009)
Humoral Immune Response to Mixed PfAMA1 Alleles; Multivalent PfAMA1 Vaccines Induce Broad Specificity
Kwadwo A. Kusi et al.
PLOS ONE (2009)
A Phase 1 study of the blood-stage malaria vaccine candidate AMA1-C1/Alhydrogel® with CPG 7909, using two different formulations and dosing intervals
Ruth D. Ellis et al.
VACCINE (2009)
Prevalence of serum neutralizing antibodies against chimpanzee adenovirus 63 and human adenovirus 5 in Kenyan Children, in the context of vaccine vector efficacy
M. Dudareva et al.
VACCINE (2009)
Comparative testing of six antigen-based malaria vaccine candidates directed toward merozoite-stage Plasmodium falciparum
David E. Arnot et al.
CLINICAL AND VACCINE IMMUNOLOGY (2008)
A diversity-covering approach to immunization with Plasmodium falciparum apical membrane antigen 1 induces broader allelic recognition and growth inhibition responses in rabbits
Edmond J. Remarque et al.
INFECTION AND IMMUNITY (2008)
Gradual Decline in Malaria-Specific Memory T Cell Responses Leads to Failure to Maintain Long-Term Protective Immunity to Plasmodium chabaudi AS Despite Persistence of B Cell Memory and Circulating Antibody
Ana Paula Freitas do Rosario et al.
JOURNAL OF IMMUNOLOGY (2008)
Immunization with plasmid DNA encoding influenza A virus nucleoprotein fused to a tissue plasminogen activator signal sequence elicits strong immune responses and protection against H5N1 challenge in mice
Mengcheng Luo et al.
JOURNAL OF VIROLOGICAL METHODS (2008)
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
Susan P. Buchbinder et al.
LANCET (2008)
Effective induction of high-titer antibodies by viral vector vaccines
Simon J. Draper et al.
NATURE MEDICINE (2008)
Safety and Immunogenicity of a Recombinant Plasmodium falciparum AMA1 Malaria Vaccine Adjuvanted with Alhydrogel™, Montanide ISA 720 or AS02
Meta Roestenberg et al.
PLOS ONE (2008)
Antibody-Mediated Growth Inhibition of Plasmodium falciparum: Relationship to Age and Protection from Parasitemia in Kenyan Children and Adults
Arlene E. Dent et al.
PLOS ONE (2008)
Apical membrane antigen 1: a malaria vaccine candidate in review
Edmond J. Remarque et al.
TRENDS IN PARASITOLOGY (2008)
In immunization with Plasmodium falciparum apical membrane antigen 1, the specificity of antibodies depends on the species immunized
Kazutoyo Miura et al.
INFECTION AND IMMUNITY (2007)
Structural basis of antigenic escape of a malaria vaccine candidate
Sheetij Dutta et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major
Patricia A. Darrah et al.
NATURE MEDICINE (2007)
Phase I dose escalation safety and immunogenicity trial of Plasmodium falciparum apical membrane protein (AMA-1) FMP2.1, adjuvanted with AS02A, in malariu-naive adults at the Walter Reed Army Institute of Research
Mark E. Polhemus et al.
VACCINE (2007)
Effect of the malaria vaccine Combination B on merozoite surface antigen 2 diversity
Christian Flueck et al.
INFECTION GENETICS AND EVOLUTION (2007)
Chimpanzee adenovirus antibodies in humans, sub-Saharan Africa
Zhiquan Xiang et al.
EMERGING INFECTIOUS DISEASES (2006)
Immune responses in mice induced by prime-boost schemes of the Plasmodium falciparum apical membrane antigen 1 (PfAMA1)-based DNA, protein and recombinant modified vaccinia Ankara vaccines
Jun Miao et al.
VACCINE (2006)
Antibodies to Plasmodium falciparum antigens vary by age and antigen in children in a malaria-holoendemic area of Kenya
K Chelimo et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2005)
Phase 1 clinical trial of apical membrane antigen 1:: an asexual blood-stage vaccine for Plasmodium falciparum malaria
EM Malkin et al.
INFECTION AND IMMUNITY (2005)
Crystal structure of the malaria vaccine candidate apical membrane antigen 1
JC Pizarro et al.
SCIENCE (2005)
Allele specificity of naturally acquired antibody responses against Plasmodium falciparum apical membrane antigen 1
A Cortes et al.
INFECTION AND IMMUNITY (2005)
Allelic polymorphisms in apical membrane antigen-1 are responsible for evasion of antibody-mediated inhibition in Plasmodium falciparum
J Healer et al.
MOLECULAR MICROBIOLOGY (2004)
A role for apical membrane antigen 1 during invasion of hepatocytes by Plasmodium falciparum sporozoites
O Silvie et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Neutralizing antibodies and CD8+ T lymphocytes both contribute to immunity to adenovirus serotype 5 vaccine vectors
SM Sumida et al.
JOURNAL OF VIROLOGY (2004)
Human antibodies to recombinant protein constructs of Plasmodium falciparum Apical Membrane Antigen 1 (AMA1) and their associations with protection from malaria
SD Polley et al.
VACCINE (2004)
Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity
DH Barouch et al.
JOURNAL OF IMMUNOLOGY (2004)
Geographical structure of diversity and differences between symptomatic and asymptomatic infections for Plasmodium falciparum vaccine candidate AMA1
A Cortes et al.
INFECTION AND IMMUNITY (2003)
In vitro studies with recombinant Plasmodium falciparum apical membrane antigen 1 (AMA1):: Production and activity of an AMA1 vaccine and generation of a multiallelic response
MC Kennedy et al.
INFECTION AND IMMUNITY (2002)
Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum
DJ Pombo et al.
LANCET (2002)
High-level expression of the malaria blood-stage vaccine candidate Plasmodium falciparum apical membrane antigen 1 and induction of antibodies that inhibit erythrocyte invasion
CHM Kocken et al.
INFECTION AND IMMUNITY (2002)
Protective efficacy of a plasmid DNA encoding Japanese encephalitis virus envelope protein fused to tissue plasminogen activator signal sequences: studies in a murine intracerebral virus challenge model
MS Ashok et al.
VACCINE (2002)
Specificity of the protective antibody response to apical membrane antigen 1
AN Hodder et al.
INFECTION AND IMMUNITY (2001)
Polymorphism in the gene encoding the apical membrane antigen-1 (AMA-1) of Plasmodium falciparum.: X.: Asembo Bay Cohort Project
AA Escalante et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2001)
CD4+ T cells acting independently of antibody contribute to protective immunity to Plasmodium chabaudi infection after apical membrane antigen 1 immunization
HJ Xu et al.
JOURNAL OF IMMUNOLOGY (2000)
分享论文
